Area of research
Surgery · Oncology
Research interest
Research interests include Pancreatitis Pathology and Treatment, Helicobacter pylori-related gastroenterology studies, Pancreatic and Hepatic Oncology Research, and Gastric Cancer Management and Outcomes.
Association of albumin trajectories and cumulative exposure with in-hospital mortality in acute pancreatitis: a retrospective cohort study.
Bifidobacterium Pseudolongum-Derived Acetate Attenuates Acute Pancreatitis Through GPR43-Mediated Suppression of M1 Macrophage Polarization.
Blood urea nitrogen to albumin ratio as a robust predictor of in-hospital mortality in patients with predicted severe acute pancreatitis: a retrospective multicenter observational study.
Gut microbiota dysbiosis exacerbates acute pancreatitis via <i>Escherichia coli</i>-driven neutrophil heterogeneity and NETosis.
A Bidirectional Association Between Helicobacter pylori Infection and Hyperlipidemia: Clinical Evidence and Mechanistic Insights.
Safety of Early Diet After Endoscopic Full-Thickness Resection of Gastric Tumor: A Propensity Match Analysis.
Association of the C-reactive protein-to-albumin-to-lymphocyte index with severe acute pancreatitis: A single-center retrospective study of 5,016 patients
Quality and reliability evaluation of pancreatic cancer-related video content on social short video platforms: a cross-sectional study
Global burden and characterization of hypertriglyceridemia-induced acute pancreatitis: results from a systematic review and a multi-center cohort study
Early versus delayed catheter drainage for patients with necrotizing pancreatitis and early persistent organ failure (TIMING): a multicenter randomized controlled trial
YouTube and TikTok as sources of information on acute pancreatitis: a content and quality analysis
Ascites characteristics in acute pancreatitis: A prognostic indicator of organ failure and mortality
Gut microbiome predicts personalized responses to dietary fiber in prediabetes: a randomized, open-label trial
Natural product Pulsatilla saponin D sensitizes BRCA-proficient ovarian cancers to PARP inhibitors through inhibiting homologous recombination repair
Helicobacter pylori activates DOPEY1 to promote p53 degradation through the USP7/TRIP12 axis in gastric tumorigenesis.
Comprehensive characterization of gastrointestinal microbiota dysbiosis in patients with refractory <i>Helicobacter pylori</i> infection
Screening of Traditional Chinese Medicine Compounds Identified the Anti– <i>Helicobacter pylori</i> Effects of Alantolactone, Decursin, and Phillygenin
Readmission of patients with hypertriglyceridemia-induced acute pancreatitis: a prospective cohort study
Cumulative intra-abdominal pressure exposure and dynamic trajectories in ICU-admitted patients reveal prognostic determinants of severe acute pancreatitis
Lactate Dehydrogenase-to-Albumin Ratio as a Predictor of In-Hospital Mortality in Predicted Severe Acute Pancreatitis: Evidence from an 18-Year Cohort Study.
Assessing the Capabilities of Novel Open-Source Artificial Intelligence-DeepSeek in Helicobacter pylori-Related Queries.
Rifaximin reduces gut-derived inflammation in severe acute pancreatitis: an experimental animal model and randomized controlled trial.
Comprehensive characterization of gastrointestinal microbiota dysbiosis in patients with refractory <i>Helicobacter pylori</i> infection.
Tegoprazan and low- or high-dose amoxicillin dual therapy versus bismuth-containing quadruple therapy for <i>Helicobacter pylori</i> eradication (TREAT): protocol for a multicenter, open-label, non-inferiority, randomized controlled trial.
40 years after the discovery of <i>Helicobacter Pylori</i>: Performing optimized "subtraction" for clinical eradication.
Efficacy and safety of intensive triglyceride-lowering therapy on reducing recurrence of hypertriglyceridemia-associated pancreatitis (REDUCE): protocol for a multicentre, randomised controlled trial.
Targeting the TNFα/TNFR1 axis alleviates the experimental acute pancreatitis
Dietary inulin ameliorates obesity-induced severe acute pancreatitis via gut-pancreas axis
Copper-Bearing Metal-Organic Framework with Mucus-Penetrating Function for the Multi-Effective Clearance of Mucosal Colonized <i>Helicobacter pylori</i>
Metal‐Organic Framework Based Mucoadhesive Nanodrugs for Multifunction <i>Helicobacter Pylori</i> Targeted Eradication, Inflammation Regulation and Gut Flora Protection